Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael P Murphy

Showing results (511-520 of 526) with videos related to

Pageof 53
Sort By:
Cell|May 1, 2012
DICER1 loss and Alu RNA induce age-related macular degeneration via the NLRP3 inflammasome and MyD88Valeria Tarallo, Yoshio Hirano, Bradley D Gelfand, et al.
Nature|March 8, 2023
Macrophage fumarate hydratase restrains mtRNA-mediated interferon productionAlexander Hooftman, Christian G Peace, Dylan G Ryan, et al.
Nature|November 11, 2014
Ischaemic accumulation of succinate controls reperfusion injury through mitochondrial ROSEdward T Chouchani, Victoria R Pell, Edoardo Gaude, et al.
Nature Cardiovascular Research|April 26, 2024
Assessment of left ventricular tissue mitochondrial bioenergetics in patients with stable coronary artery diseaseRichard E Jones, Anja V Gruszczyk, Christina Schmidt, et al.
Cell Metabolism|January 22, 2025
Ergothioneine improves healthspan of aged animals by enhancing cGPDH activity through CSE-dependent persulfidationDunja Petrovic, Luke Slade, Yiorgos Paikopoulos, et al.
JACC. Cardiooncology|January 6, 2021
Allogeneic Mesenchymal Cell Therapy in Anthracycline-Induced Cardiomyopathy Heart Failure Patients: The CCTRN SENECA TrialRoberto Bolli, Emerson C Perin, James T Willerson, et al.
European Journal of Heart Failure|April 3, 2021
A Phase II study of autologous mesenchymal stromal cells and c-kit positive cardiac cells, alone or in combination, in patients with ischaemic heart failure: the CCTRN CONCERT-HF trialRoberto Bolli, Raul D Mitrani, Joshua M Hare, et al.
Nature Communications|January 3, 2025
Paracrine role of endothelial IGF-1 receptor in depot-specific adipose tissue adaptation in male miceCheukyau Luk, Katherine I Bridge, Nele Warmke, et al.
Science Immunology|August 12, 2022
Immunodeficiency, autoimmunity, and increased risk of B cell malignancy in humans with <i>TRAF3</i> mutationsWilliam Rae, John M Sowerby, Dorit Verhoeven, et al.
Nature|March 29, 2018
Itaconate is an anti-inflammatory metabolite that activates Nrf2 via alkylation of KEAP1Evanna L Mills, Dylan G Ryan, Hiran A Prag, et al.
Pageof 53

Showing results (511-520 of 526) with videos related to

Sort By:
Pageof 53
Cell|May 1, 2012
DICER1 loss and Alu RNA induce age-related macular degeneration via the NLRP3 inflammasome and MyD88Valeria Tarallo, Yoshio Hirano, Bradley D Gelfand, et al.
Nature|March 8, 2023
Macrophage fumarate hydratase restrains mtRNA-mediated interferon productionAlexander Hooftman, Christian G Peace, Dylan G Ryan, et al.
Nature|November 11, 2014
Ischaemic accumulation of succinate controls reperfusion injury through mitochondrial ROSEdward T Chouchani, Victoria R Pell, Edoardo Gaude, et al.
Nature Cardiovascular Research|April 26, 2024
Assessment of left ventricular tissue mitochondrial bioenergetics in patients with stable coronary artery diseaseRichard E Jones, Anja V Gruszczyk, Christina Schmidt, et al.
Cell Metabolism|January 22, 2025
Ergothioneine improves healthspan of aged animals by enhancing cGPDH activity through CSE-dependent persulfidationDunja Petrovic, Luke Slade, Yiorgos Paikopoulos, et al.
JACC. Cardiooncology|January 6, 2021
Allogeneic Mesenchymal Cell Therapy in Anthracycline-Induced Cardiomyopathy Heart Failure Patients: The CCTRN SENECA TrialRoberto Bolli, Emerson C Perin, James T Willerson, et al.
European Journal of Heart Failure|April 3, 2021
A Phase II study of autologous mesenchymal stromal cells and c-kit positive cardiac cells, alone or in combination, in patients with ischaemic heart failure: the CCTRN CONCERT-HF trialRoberto Bolli, Raul D Mitrani, Joshua M Hare, et al.
Nature Communications|January 3, 2025
Paracrine role of endothelial IGF-1 receptor in depot-specific adipose tissue adaptation in male miceCheukyau Luk, Katherine I Bridge, Nele Warmke, et al.
Science Immunology|August 12, 2022
Immunodeficiency, autoimmunity, and increased risk of B cell malignancy in humans with <i>TRAF3</i> mutationsWilliam Rae, John M Sowerby, Dorit Verhoeven, et al.
Nature|March 29, 2018
Itaconate is an anti-inflammatory metabolite that activates Nrf2 via alkylation of KEAP1Evanna L Mills, Dylan G Ryan, Hiran A Prag, et al.
Pageof 53